Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]

Developing technologies for personalised treatment

Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer...

Developing technologies for personalised treatment ( Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer, Salamanca, Spain )

Genes, chromosomes and the treatment of bladder cancer

Dr Jonathan Rosenburg - Memorial Sloan Kettering Cancer Center, New York, USA

Genes, chromosomes and the treatment of bladder cancer ( Dr Jonathan Rosenburg - Memorial Sloan Kettering Cancer Center, New York, USA )

Analysing the efficacy of treatment through Response Evaluation Criteria in...

Dr Yves Menu – Saint Antoine Hospital, Paris, France

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )

Development and expansion of the IFOM-IEO campus

Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM

Development and expansion of the IFOM-IEO campus ( Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM )

Histology and non-histology driven therapy for soft tissue sarcomas and the...

Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy

Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative ( Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy )

Putting the theory of personalised medicine into practice

Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...

Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA

Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's...

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen...

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma ( Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Prof John Gribben - Bart’s and )

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK

Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )

The ceRNA Hypothesis and the non-coding revolution in cancer research and...

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA

The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )

Australia Pancreatic Cancer Genome Initiative

Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst...

Australia Pancreatic Cancer Genome Initiative ( Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia )

More from ecancer